Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-26 @ 12:00 AM
Study NCT ID:
NCT00234494
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2005-10-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
Sponsor:
Christopher Sweeney, MBBS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-05
First Submit QC Date:
None
Study First Post Date:
2005-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-19
Results First Submit QC Date:
None
Results First Post Date:
2016-03-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-16
Last Update Post Date:
2016-03-14
Last Update Post Date Type:
ESTIMATED